TheEdgeResearch
Home / Stocks / ONSS

Onassis Holdings Corp. (ONSS)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +49.25%
Market Cap
$3,926
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-1.55
52-Wk Range
0.0001-0.01
CEO
Eliron Yaron
Country
US
Currency
USD

Onassis Holdings Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, up 49.25% on the session, giving a market capitalisation of $3,926. On trailing twelve-month figures it carries a trailing P/E of -0.18, a net margin of 0.0%. Its beta of -1.55 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.18
Price / Sales
0.00
Price / Book
-0.14
EV / EBITDA
-74.67
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-3.70
Current ratio
0.61
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
105
IPO date
2013-02-12
Headquarters
New York City, NY, US
About Onassis Holdings Corp.

Onassis Holdings Corp. operates across a diverse portfolio of industries, including wellness, cannabidiol (CBD) and hemp oil, and cosmetics. The company delivers a variety of products and services specifically tailored for businesses within the CBD and hemp oil sector, serving markets in both the United States and Europe. In addition, it is engaged in the development and commercialization of electronic disinfection apparatus. This entity was formerly recognized as Onassis Mining Group, Inc. before officially changing its name to Onassis Holdings Corp. in September 2019. The corporate headquarters for Onassis Holdings Corp. are located in New York, New York.

Comparable companies

Onassis Holdings Corp. is most often compared with the following Healthcare names:

ARYXATTBFAXMPISOLFNSRSNUNZOWCPQEBRVFRMWIBFF
More research on ONSS
ONSS technical analysis ONSS TheEdge Score Compare against peers
Open full interactive analysis & DCF →